Lipophilic Cations as Mitochondria-Targeting Moieties: Recent Progress and Design Principles for Medicinal Chemistry

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Mitochondria-targeting technology using lipophilic cation-small molecule conjugates has existed for over 50 years.
• The triphenylphosphonium (TPP) cation is a well-established mitochondria-targeting moiety (MTM).
• Initial research focused on TPP's accumulation in mitochondria and its role in cation import.

Purpose of the Study:

• To present the current understanding of the biological mechanisms of action for mitochondria-targeting conjugates.
• To describe validation methods for these conjugates.
• To overview novel MTMs and propose a rational development approach for future therapeutics.

Main Methods:

• Literature review and synthesis of existing research on mitochondria-targeting moieties.
• Analysis of biological mechanisms of action and validation techniques.
• Overview of recently developed novel MTMs.

Main Results:

• TPP's intrinsic biological effects, beyond cargo delivery, were recognized later.
• Novel MTMs have been developed beyond the archetypal TPP.
• A rational approach for developing new MTMs for future therapeutics is proposed.

Conclusions:

• Understanding TPP's biological effects spurred the development of new MTMs.
• Recent advances enable the rational design of novel MTMs.
• This work lays the foundation for future mitochondria-targeting therapeutics (MITACs).